Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FSYXP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,125
Award facts
- Contract value 100% obligated
- $3,124.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,124.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on October 29, 2025, utilizes firm fixed-price pricing with an ultimate completion date of November 20, 2025. This delivery order carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The contract will be performed at the company's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy under which the Defense Logistics Agency establishes regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's inclusion as a prime vendor contractor demonstrates its established capability to fulfill the specialized pharmaceutical requirements of the federal military medical system across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DB26FSYXP?
SPE2DB26FSYXP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FSYXP worth?
The government has obligated $3,125 on SPE2DB26FSYXP.
Is contract SPE2DB26FSYXP an order under another contract?
Yes. SPE2DB26FSYXP is a delivery order under SPE2DB25D9349, an indefinite delivery contract.
Was contract SPE2DB26FSYXP competed?
The extent of competition for SPE2DB26FSYXP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award